focus -WSS

focus

author：explore 2025-10-03 00:39:19 - browse：59

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Christmas in the PICU brings some surprising joy

WSS

Phenylephrine and the overlooked value of the placebo effect

Editas, Vertex strike deal on CRISPR

Can sheer will power keep patients alive in their dying hours?

Medicare Advantage beneficiaries sue Humana over algorithm use

SNAP should offer more nutrition education

Editas, Vertex strike deal on CRISPR

knowledge

focus

leisure time

Cancer drug shortages should be causing more outrage

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage beneficiaries sue Humana over algorithm use

Psychedelics group wrestles with new pharma identity

When women are denied an abortion, their children fare worse than peers

Tori Bowie and the unacceptable rates of Black maternal death

Violet CEO on training clinicians to promote more inclusive care

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

entertainment

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

HCA sued by state AG for quality issues at Mission Health

Violet CEO on training clinicians to promote more inclusive care

What to expect at HLTH 2023, the health care industry conference

Hospitals owned by private equity see complications spike 25%

Albert Bourla of Pfizer: worst biopharma CEO of 2023

entertainment

leisure time

hotspot

focus